Yuji Kishimoto Selected Research

Yuji Kishimoto Research Topics

6	Leukemia 01/2014 - 12/2005
4	Rheumatoid Arthritis 03/2022 - 10/2010
3	Experimental Arthritis 03/2013 - 01/2004
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2010 - 12/2005
2	Acute Promyelocytic Leukemia 07/2007 - 03/2007
1	Disseminated Intravascular Coagulation 01/2014
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2010
1	Stress Fractures (Stress Fracture) 10/2010
1	Philadelphia Chromosome 10/2010
1	Rupture 10/2010
1	Mastitis 01/2010
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 09/2009
1	Bovine Mastitis 10/2008
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 11/2007
1	Hemorrhage 03/2007
1	Pneumonia (Pneumonitis) 03/2007
1	Arthritis (Polyarthritis) 01/2007
1	Bone Resorption 01/2007
1	Disease Progression 10/2004
1	Thrombosis (Thrombus) 10/2004
1	Lymphoma (Lymphomas) 10/2004
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 05/2004
1	Membranous Glomerulonephritis (Membranous Nephropathy) 10/2003
1	Nephrotic Syndrome (Syndrome, Nephrotic) 10/2003
1	Aplastic Anemia (Anemia, Hypoplastic) 09/2003
1	Pain (Aches) 08/2002

4	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2014 - 03/2007
2	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2012 - 03/2010
1	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 03/2022
1	GlucocorticoidsIBA 03/2022
1	Diphosphonates (Bisphosphonates)IBA 02/2022
1	CD56 AntigenIBA 01/2014
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2014
1	Etanercept (Enbrel)FDA Link 03/2013
1	CytokinesIBA 03/2013
1	AnthracyclinesIBA 11/2012
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2010
1	Imatinib Mesylate (Gleevec)FDA Link 10/2010
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 03/2010
1	Ribosomal DNA (rDNA)IBA 01/2010
1	Dacarbazine (DIC)FDA LinkGeneric 01/2010
1	romiplostim FDA Link 09/2009
1	Inosine Triphosphate (ITP)IBA 09/2009
1	Drinking WaterIBA 10/2008
1	DNA (Deoxyribonucleic Acid)IBA 11/2007
1	promyelocytic leukemia-retinoic acid receptor alpha fusion oncoproteinIBA 07/2007
1	Fibrinogen (Factor I)FDA Link 03/2007
1	RANK LigandIBA 01/2007
1	AcidsIBA 01/2007
1	Rituximab (Mabthera)FDA Link 10/2004
1	Antiphospholipid AntibodiesIBA 10/2004
1	Interferon-alpha (Interferon Alfa)IBA 05/2004
1	Tartrate-Resistant Acid PhosphataseIBA 01/2004
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 09/2003
1	Oxygen (Dioxygen)IBA 08/2002
1	Pain-FreeIBA 08/2002

7	Therapeutics 10/2010 - 05/2004
3	Drug Therapy (Chemotherapy) 01/2014 - 07/2007
3	Hematopoietic Stem Cell Transplantation 10/2010 - 10/2003
2	Remission Induction 03/2010 - 03/2007
2	Stem Cell Transplantation 03/2010 - 05/2004
1	Intra-Articular Injections 03/2022
1	Synovectomy 10/2010
1	Induction Chemotherapy 03/2010
1	Maintenance Chemotherapy 07/2007
1	Splenectomy 10/2004
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 10/2004
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 10/2003
1	Transplantation 09/2003